ACTISEVEN Trademark

Trademark Overview

On Friday, October 28, 2011, a trademark application was filed for ACTISEVEN with the United States Patent and Trademark Office. The USPTO has given the ACTISEVEN trademark a serial number of 79106488. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, October 28, 2021. This trademark is owned by LABORATOIRE FRANCAIS DU; FRACTIONNEMENT; ET DES BIOTECHNOLOGIES. The ACTISEVEN trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for treating coagulation disorders

Scientific and industrial research relating to hemostasis; conducting clinical trials for others relating to hemostasis
actiseven

General Information

Serial Number79106488
Word MarkACTISEVEN
Filing DateFriday, October 28, 2011
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, October 28, 2021
Registration Number4204192
Registration DateTuesday, September 11, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 26, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations for treating coagulation disorders
Pseudo MarkACTI SEVEN
Goods and ServicesScientific and industrial research relating to hemostasis; conducting clinical trials for others relating to hemostasis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, April 12, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, April 12, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLABORATOIRE FRANCAIS DU; FRACTIONNEMENT; ET DES BIOTECHNOLOGIES
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressF-91940 LES ULIS
FR
Party NameLABORATOIRE FRANCAIS DU; FRACTIONNEMENT; ET DES BIOTECHNOLOGIES
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressF-91940 LES ULIS
FR
Party NameLABORATOIRE FRANCAIS DU; FRACTIONNEMENT; ET DES BIOTECHNOLOGIES
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressF-91940 LES ULIS
FR

Trademark Events

Event DateEvent Description
Sunday, May 22, 2022NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sunday, May 22, 2022DEATH OF INTERNATIONAL REGISTRATION
Friday, April 9, 2021NEW REPRESENTATIVE AT IB RECEIVED
Thursday, April 8, 2021CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Saturday, April 3, 2021CORRECTION TRANSACTION RECEIVED FROM IB
Friday, March 5, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, February 21, 2020TOTAL INVALIDATION PROCESSED BY THE IB
Saturday, January 11, 2020GENERIC MADRID TRANSACTION SENT TO IB
Saturday, January 11, 2020GENERIC MADRID TRANSACTION CREATED
Thursday, December 12, 2019TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, April 12, 2019CANCELLED SECTION 71
Monday, September 11, 2017COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, March 27, 2015NEW REPRESENTATIVE AT IB RECEIVED
Monday, July 21, 2014NEW REPRESENTATIVE AT IB RECEIVED
Monday, May 6, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, April 17, 2013FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, April 17, 2013FINAL DISPOSITION PROCESSED
Tuesday, December 11, 2012FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, December 10, 2012NOTIFICATION PROCESSED BY IB
Tuesday, September 11, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, June 26, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 26, 2012PUBLISHED FOR OPPOSITION
Wednesday, June 6, 2012NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 6, 2012NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, June 6, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 21, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, May 17, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 17, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 17, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 27, 2012ASSIGNED TO LIE
Friday, April 20, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, February 25, 2012REFUSAL PROCESSED BY IB
Monday, February 6, 2012NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, February 6, 2012REFUSAL PROCESSED BY MPU
Friday, February 3, 2012NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, February 2, 2012NON-FINAL ACTION WRITTEN
Tuesday, January 31, 2012ASSIGNED TO EXAMINER
Tuesday, December 27, 2011APPLICATION FILING RECEIPT MAILED
Friday, December 23, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 22, 2011SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

actiseven hemostasis relating conducting clinical others trials research industrial treating preparations